Cargando…
Nanopore sequencing of full-length BRCA1 mRNA transcripts reveals co-occurrence of known exon skipping events
BACKGROUND: Laboratory assays evaluating the effect of DNA sequence variants on BRCA1 mRNA splicing may contribute to classification by providing molecular evidence. However, our knowledge of normal and aberrant BRCA1 splicing events to date has been limited to data derived from assays targeting par...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5706335/ https://www.ncbi.nlm.nih.gov/pubmed/29183387 http://dx.doi.org/10.1186/s13058-017-0919-1 |
_version_ | 1783282210766323712 |
---|---|
author | de Jong, Lucy C. Cree, Simone Lattimore, Vanessa Wiggins, George A. R. Spurdle, Amanda B. Miller, Allison Kennedy, Martin A. Walker, Logan C. |
author_facet | de Jong, Lucy C. Cree, Simone Lattimore, Vanessa Wiggins, George A. R. Spurdle, Amanda B. Miller, Allison Kennedy, Martin A. Walker, Logan C. |
author_sort | de Jong, Lucy C. |
collection | PubMed |
description | BACKGROUND: Laboratory assays evaluating the effect of DNA sequence variants on BRCA1 mRNA splicing may contribute to classification by providing molecular evidence. However, our knowledge of normal and aberrant BRCA1 splicing events to date has been limited to data derived from assays targeting partial transcript sequences. This study explored the utility of nanopore sequencing to examine whole BRCA1 mRNA transcripts and to provide accurate categorisation of in-frame and out-of-frame splicing events. METHODS: The exon structure of BRCA1 transcripts from a previously studied control lymphoblastoid cell line were assessed using MinION nanopore sequencing of long-range reverse transcriptase-PCR amplicons. RESULTS: Our study identified and characterised 32 complete BRCA1 isoforms, including 18 novel isoforms which showed skipping of multiple contiguous and/or non-contiguous exons. Furthermore, we show that known BRCA1 exon skipping events, such as Δ(9,10) and Δ21, can co-occur in a single transcript, with some isoforms containing four or more alternative splice junctions. Fourteen novel isoforms were formed entirely from a combination of previously identified alternative splice junctions, suggesting that the total number of BRCA1 isoforms might be lower than the number of splicing events reported previously. CONCLUSIONS: Our results highlight complexity in BRCA1 transcript structure that has not been described previously. This finding has key implications for predicting the translation frame of splicing transcripts, important for interpreting the clinical significance of spliceogenic variants. Future research is warranted to quantitatively assess full-length BRCA1 transcript levels, and to assess the application of nanopore sequencing for routine evaluation of potential spliceogenic variants. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13058-017-0919-1) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-5706335 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-57063352017-12-05 Nanopore sequencing of full-length BRCA1 mRNA transcripts reveals co-occurrence of known exon skipping events de Jong, Lucy C. Cree, Simone Lattimore, Vanessa Wiggins, George A. R. Spurdle, Amanda B. Miller, Allison Kennedy, Martin A. Walker, Logan C. Breast Cancer Res Research Article BACKGROUND: Laboratory assays evaluating the effect of DNA sequence variants on BRCA1 mRNA splicing may contribute to classification by providing molecular evidence. However, our knowledge of normal and aberrant BRCA1 splicing events to date has been limited to data derived from assays targeting partial transcript sequences. This study explored the utility of nanopore sequencing to examine whole BRCA1 mRNA transcripts and to provide accurate categorisation of in-frame and out-of-frame splicing events. METHODS: The exon structure of BRCA1 transcripts from a previously studied control lymphoblastoid cell line were assessed using MinION nanopore sequencing of long-range reverse transcriptase-PCR amplicons. RESULTS: Our study identified and characterised 32 complete BRCA1 isoforms, including 18 novel isoforms which showed skipping of multiple contiguous and/or non-contiguous exons. Furthermore, we show that known BRCA1 exon skipping events, such as Δ(9,10) and Δ21, can co-occur in a single transcript, with some isoforms containing four or more alternative splice junctions. Fourteen novel isoforms were formed entirely from a combination of previously identified alternative splice junctions, suggesting that the total number of BRCA1 isoforms might be lower than the number of splicing events reported previously. CONCLUSIONS: Our results highlight complexity in BRCA1 transcript structure that has not been described previously. This finding has key implications for predicting the translation frame of splicing transcripts, important for interpreting the clinical significance of spliceogenic variants. Future research is warranted to quantitatively assess full-length BRCA1 transcript levels, and to assess the application of nanopore sequencing for routine evaluation of potential spliceogenic variants. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13058-017-0919-1) contains supplementary material, which is available to authorized users. BioMed Central 2017-11-28 2017 /pmc/articles/PMC5706335/ /pubmed/29183387 http://dx.doi.org/10.1186/s13058-017-0919-1 Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Article de Jong, Lucy C. Cree, Simone Lattimore, Vanessa Wiggins, George A. R. Spurdle, Amanda B. Miller, Allison Kennedy, Martin A. Walker, Logan C. Nanopore sequencing of full-length BRCA1 mRNA transcripts reveals co-occurrence of known exon skipping events |
title | Nanopore sequencing of full-length BRCA1 mRNA transcripts reveals co-occurrence of known exon skipping events |
title_full | Nanopore sequencing of full-length BRCA1 mRNA transcripts reveals co-occurrence of known exon skipping events |
title_fullStr | Nanopore sequencing of full-length BRCA1 mRNA transcripts reveals co-occurrence of known exon skipping events |
title_full_unstemmed | Nanopore sequencing of full-length BRCA1 mRNA transcripts reveals co-occurrence of known exon skipping events |
title_short | Nanopore sequencing of full-length BRCA1 mRNA transcripts reveals co-occurrence of known exon skipping events |
title_sort | nanopore sequencing of full-length brca1 mrna transcripts reveals co-occurrence of known exon skipping events |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5706335/ https://www.ncbi.nlm.nih.gov/pubmed/29183387 http://dx.doi.org/10.1186/s13058-017-0919-1 |
work_keys_str_mv | AT dejonglucyc nanoporesequencingoffulllengthbrca1mrnatranscriptsrevealscooccurrenceofknownexonskippingevents AT creesimone nanoporesequencingoffulllengthbrca1mrnatranscriptsrevealscooccurrenceofknownexonskippingevents AT lattimorevanessa nanoporesequencingoffulllengthbrca1mrnatranscriptsrevealscooccurrenceofknownexonskippingevents AT wigginsgeorgear nanoporesequencingoffulllengthbrca1mrnatranscriptsrevealscooccurrenceofknownexonskippingevents AT spurdleamandab nanoporesequencingoffulllengthbrca1mrnatranscriptsrevealscooccurrenceofknownexonskippingevents AT nanoporesequencingoffulllengthbrca1mrnatranscriptsrevealscooccurrenceofknownexonskippingevents AT millerallison nanoporesequencingoffulllengthbrca1mrnatranscriptsrevealscooccurrenceofknownexonskippingevents AT kennedymartina nanoporesequencingoffulllengthbrca1mrnatranscriptsrevealscooccurrenceofknownexonskippingevents AT walkerloganc nanoporesequencingoffulllengthbrca1mrnatranscriptsrevealscooccurrenceofknownexonskippingevents |